Here, we show that PYCR1 and collagen upregulation co-occur in many types of tumours, and anticipate that further work exploring PYCR1 as a therapeutic target to attack both cancer and stromal cells may result in further development of strategies to treat cancer. Here, PYCR1 is linked to neoplasm.